College of Pharmacy News

An independent advisory committee to the FDA has determined that phenylephrine, a popular ingredient in many over-the-counter allergy and cold medicines, is ineffective in tablet form. CNN and numerous other national news outlets quote from the College of Pharmacy's Associate Dean for Healthcare Partnerships Dr. Diane Ginsburg, who serves on the committee, regarding this decision.

The University of Texas at Austin College of Pharmacy placed in the top ten in the entire country in the percentage of match placements with 91%, compared to the national match placement average of 82%.

The Texas Pharmacy Alumni Association has selected Emmanuel Enwere, Pharm.D., M.S., CPHIMS, Jamie C. Barner, Ph.D., FAACP, FAPhA and M. Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP as the 2022 Alumni Award recipients. This year's winners will be honored on November 12, 2022 at the Texas Pharmacy Homecoming Tailgate, generously sponsored by H-E-B.

Researchers in UT Pharmacy's Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have earned a bevy of national and international awards for their work in pharmaceutical drug delivery and 3D printing personalized medicines.

From student scholarships to national recognition awards to prestigious appointments, the UT Pharmacy community has a lot to celebrate and be proud of right now.

Dr. Diane Ginsburg has been appointed to the Provost’s Distinguished Service Academy for her excellence in mentorship and demonstrated mastery across scholarship, teaching, leadership and service.

Pharmacy schools across the country completed their 2022 Phase I and Phase II residency matches for new or upcoming graduates of their Doctor of Pharmacy (Pharm.D.) programs. The University of Texas at Austin College of Pharmacy placed in the top ten of all pharmacy schools in the nation, and number one in Texas.

Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.

The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.

The college's Pharmaceutical Engineering and 3D Printing (PharmE3D) labs, led by Assistant Professor in Molecular Pharmaceutics and Drug Delivery Mohammed (Mo) Maniruzzaman, Ph.D., has recently earned several national and international awards and scholarships for outstanding research contributions to the field of pharmaceutical science and technology.